Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1231P (RNA, U6 small nuclear 1231, pseudogene) is a processed pseudogene derived from the U6 small nuclear RNA gene, which itself is a component of the spliceosomal small nuclear RNAs (snRNAs)[1][3][5][7]. Pseudogenes like RNU6-1231P are generally considered non-functional relics; they originate via retrotransposition, typically lacking the regulatory elements and functionality of the active gene products[2][4]. RNU6-1231P does not encode a protein and has no recognized biological or therapeutic role. It is not considered a therapeutic target, and there is currently no evidence linking it to disease, drug interactions, or biomarker utility[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1231, pseudogene (RNU6-1231P).